SCHEMBL564857

SCHEMBL564857

CC(C)CN(Cc1cc(Cl)c2c(c1)OCCCO2)C(=O)C(C)CN(C)c1ccco1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PROKR2 Q8NFJ6 5/20 0.54
NPC1 O15118 2/20 0.35
RAB9A P51151 2/20 0.35
SMN1; SMN2 Q16637 2/20 0.35
MAPK8 P45983 1/20 0.35
TP53 P04637 1/20 0.34
CTNNB1 P35222 3/20 0.32
WNT3A P56704 3/20 0.32
ALDH1A1 P00352 3/20 0.31
HPGD P15428 2/20 0.31
MEN1 O00255 1/20 0.31
KMT2A Q03164 1/20 0.31
KDM4E B2RXH2 1/20 0.31
GAA P10253 1/20 0.31
TSHR P16473 1/20 0.31
HDAC3 O15379 1/20 0.30
HDAC4 P56524 1/20 0.30
HDAC1 Q13547 1/20 0.30
HDAC7 Q8WUI4 1/20 0.30
HDAC2 Q92769 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL564204 0.85 PROKR2 (0.56) PROKR2NPC1RAB9AMAPK8CTNNB1
SCHEMBL565671 0.84 PROKR2 (0.52) PROKR2MAPK8
SCHEMBL565424 0.83 PROKR2 (0.53) PROKR2MAPK8ALDH1A1
SCHEMBL564150 0.83 PROKR2 (0.54) PROKR2MAPK8CTNNB1WNT3A
SCHEMBL565624 0.83 PROKR2 (0.56) PROKR2NPC1RAB9ASMN1; SMN2MAPK8
SCHEMBL565001 0.83 PROKR2 (0.56) PROKR2MAPK8GAA
SCHEMBL564858 0.82 PROKR2 (0.65) PROKR2NPC1RAB9ASMN1; SMN2MAPK8
SCHEMBL564953 0.82 PROKR2 (0.54) PROKR2MAPK8TP53CTNNB1WNT3A
SCHEMBL565620 0.82 PROKR2 (0.55) PROKR2MAPK8ALDH1A1
SCHEMBL565182 0.82 PROKR2 (0.54) PROKR2MAPK8ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8722896-B2 Prokineticin receptor antagonists and uses thereof THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2014-05-13 US disclosed
US-20120035149-A1 Prokineticin Receptor Antagonists And Uses Thereof THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2012-02-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120035149-A1 Prokineticin Receptor Antagonists And Uses Thereof PROKR2, PROKR1, GIPR PROKR2 1/4885NPC1 3472/4885RAB9A 1704/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.